The Pathway to a Universal Influenza Vaccine

Catharine I Paules; Hilary D Marston; Robert W Eisinger; David Baltimore; Anthony S Fauci

doi:10.1016/j.immuni.2017.09.007

The Pathway to a Universal Influenza Vaccine

Immunity. 2017 Oct 17;47(4):599-603. doi: 10.1016/j.immuni.2017.09.007.

Authors

Catharine I Paules¹, Hilary D Marston¹, Robert W Eisinger¹, David Baltimore², Anthony S Fauci³

Affiliations

¹ Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
² California Institute of Technology, Pasadena, CA 91125, USA.
³ Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: afauci@niaid.nih.gov.

PMID: 29045889
DOI: 10.1016/j.immuni.2017.09.007

Abstract

Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.

Publication types

Congress

MeSH terms

Animals
Disease Models, Animal*
Ferrets
Humans
Influenza A virus / immunology*
Influenza Vaccines / administration & dosage
Influenza Vaccines / immunology*
Influenza, Human / immunology*
Influenza, Human / prevention & control
Influenza, Human / virology
National Institute of Allergy and Infectious Diseases (U.S.)
United States

Substances

Influenza Vaccines